Aspen Aerogels
ASPN
54 hedge funds and large institutions have $70.9M invested in Aspen Aerogels in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
2% more funds holding
Funds holding: 53 → 54 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.87% less ownership
Funds ownership: 75.32% → 73.45% (-1.9%)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
32% less capital invested
Capital invested by funds: $105M → $70.9M (-$33.7M)
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q4 2016 in Review
54 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q4 2016, worth a combined $70.9M — down 32% from $105M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ASPN positions and 7 closed out — a net gain of 2 holders — while 14 added to existing stakes and 16 trimmed.
The largest buyer was Ariel Investments, adding an estimated $4.55M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $16.2M sold.
- 54 institutional investors held Aspen Aerogels (ASPN) as of Q4 2016, up from 53 in Q3 2016.
- Funds reported $70.9M of Aspen Aerogels stock for Q4 2016, down 32% quarter-over-quarter.
- 9 funds opened new Aspen Aerogels positions in Q4 2016 and 7 closed out, a net change of +2 holders.
- The largest Aspen Aerogels buyer in Q4 2016 was Ariel Investments, an estimated $4.55M added.
- The largest Aspen Aerogels seller in Q4 2016 was T. Rowe Price Associates, an estimated $16.2M sold.
Based on aggregated 13F filings for Q4 2016.